web 2086 has been researched along with pentoxifylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adi, S; Feingold, KR; Fiers, W; Grunfeld, C; Moser, A; Soued, M | 1 |
| Evanson, OA; Weiss, DJ | 1 |
2 other study(ies) available for web 2086 and pentoxifylline
| Article | Year |
|---|---|
Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.
Topics: Animals; Aspirin; Azepines; Cholesterol; Fatty Acids; Ibuprofen; Interleukin-6; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oleic Acid; Oleic Acids; Pentoxifylline; Phenoxybenzamine; Platelet Activating Factor; Propranolol; Rats; Rats, Inbred Strains; Reference Values; Triazoles; Triglycerides; Tumor Necrosis Factor-alpha | 1990 |
Evaluation of lipopolysaccharide-induced activation of equine neutrophils.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Azepines; CD11 Antigens; CD18 Antigens; Cell Degranulation; Complement System Proteins; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Flow Cytometry; Horses; Interleukin-8; Lipopolysaccharides; Neutrophil Activation; Neutrophils; Pentoxifylline; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Tumor Necrosis Factor-alpha | 2002 |